Foundayo is a small molecule whereas Zepbound and Wegovy are peptides, which require more intensive manufacturing processes, a barrier Ricks thinks will hinder generic versions of Wegovy that have recently launched in some other countries, including India
GLP-1 Agonists Market: COMPANY EVALUATION MATRIX In the GLP-1 agonists market matrix, Novo Nordisk (Star) stands out as the leading player, supported by a strong product portfolio and global market presence, driving widespread usage in diabetes and obesity management
The FLOW trial, which studied semaglutide in people with diabetes and chronic kidney disease, found that semaglutide reduced the risk of kidney disease progression and kidney-related death
Published 2022 Jan 10
Industry-leading prior authorization concierge
The FDA has warned consumers not to purchase unapproved GLP-1 drugs, including products containing Semaglutide, tirzepatide, or retatrutide that are falsely labeled for research purposes or not for human consumption